SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Key facts: ImmunityBio bladder trial meets endpoint; Q3 sales rise 53%

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.

IBRX

Related stories